DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Premarin (Conjugated Estrogens) - Adverse Event Reports - Death - Breast Cancer

 



Index of reports > Cases resulting in death (34) > Cases with Breast Cancer (5)

Below is the selection of adverse event reports related to Premarin (Conjugated Estrogens) that includes cases resulting in death where reactions include breast cancer.

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-10-04

Patient: female

Adverse reactions / side effects: Breast Cancer, Cardiac Disorder

Adverse event resulted in: death

Suspect drug(s):
Prempro

Medroxyprogesterone Acetate

Medroxyprogesterone Acetate
    Indication: Hormone Replacement Therapy

Medroxyprogesterone Acetate
    Indication: Menopause

Premarin



Adverse event in 60 year old female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-06-05

Patient: 60 year old female

Adverse reactions / side effects: Breast Cancer, Acute Myocardial Infarction

Adverse event resulted in: death

Suspect drug(s):
Medroxyprogesterone Acetate
    Dosage: oral
    Administration route: Oral
    Start date: 1995-01-01
    End date: 2000-01-01

Premarin
    Dosage: oral
    Administration route: Oral
    Start date: 1995-01-01
    End date: 2000-01-01

Prempro
    Dosage: oral
    Administration route: Oral
    Start date: 2000-01-01
    End date: 2003-01-01



Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a consumer/non-health professional from United States on 2007-05-21

Patient: female

Adverse reactions / side effects: Breast Cancer, Acute Myocardial Infarction

Adverse event resulted in: death

Suspect drug(s):
Prempro
    Dosage: unknown
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1998-01-01
    End date: 2003-03-01

Medroxyprogesterone
    Dosage: unknown
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1995-11-01
    End date: 1997-01-01

Cycrin

Premarin
    Dosage: unknown
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1995-11-01
    End date: 1997-01-01

Premarin
    Dosage: unknown
    Administration route: Oral



Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-03-07

Patient: female

Adverse reactions / side effects: Breast Cancer

Adverse event resulted in: death

Suspect drug(s):
Provera
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1991-09-01
    End date: 1996-02-01

Premarin
    Indication: Hormone Replacement Therapy
    Start date: 1991-09-01
    End date: 2000-05-01



Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-02-27

Patient: female, weighing 79.4 kg (174.6 pounds)

Adverse reactions / side effects: Breast Cancer

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Activella
    Dosage: unknown
    Indication: Menopausal Symptoms
    Start date: 2002-02-20
    End date: 2002-12-01

Premarin
    Dosage: .625 mg, unk
    Indication: Menopausal Symptoms
    Start date: 1994-08-01
    End date: 1995-12-01

Prempro
    Dosage: unknown
    Indication: Menopausal Symptoms
    Start date: 1995-12-01
    End date: 1996-01-01

Prempro
    Dosage: unknown
    Start date: 1998-02-01
    End date: 2001-03-01

Premphase 14 / 14
    Dosage: unknown
    Indication: Menopausal Symptoms
    Start date: 1997-01-01
    End date: 1998-01-01

Provera
    Dosage: 10 mg, unk
    Indication: Menopausal Symptoms
    Start date: 1994-08-01
    End date: 1995-12-01

Medroxyprogesterone
    Dosage: unknown
    Indication: Menopausal Symptoms

Other drugs received by patient: Evista; Vitamins NOS

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009